Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis

Poiesz, 1980, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc Natl Acad Sci USA, 77, 7415, 10.1073/pnas.77.12.7415 Yoshida, 1982, Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease, Proc Natl Acad Sci USA, 79, 2031, 10.1073/pnas.79.6.2031 Uchiyama, 1977, Adult T-cell leukemia: clinical and hematologic features of 16 cases, Blood, 50, 481, 10.1182/blood.V50.3.481.481 Osame, 1986, HTLV-I associated myelopathy, a new clinical entity, Lancet, 1, 1031, 10.1016/S0140-6736(86)91298-5 Yamaguchi, 1994, Human T-lymphotropic virus type I in Japan, Lancet, 343, 213, 10.1016/S0140-6736(94)90994-6 Takatsuki, 2005, Discovery of adult T-cell leukemia, Retrovirology, 2, 16, 10.1186/1742-4690-2-16 Gessain, 2012, Epidemiological aspects and world distribution of HTLV-1 infection, Front Microbiol, 3, 388, 10.3389/fmicb.2012.00388 Tajima, 1990, The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group, Int J Cancer, 45, 237, 10.1002/ijc.2910450206 Satake, 2012, Current prevalence of HTLV-1 in Japan as determined by screening of blood donors, J Med Virol, 84, 327, 10.1002/jmv.23181 Iwanaga, 2012, Adult T-cell leukemia: a review of epidemiological evidence, Front Microbiol, 3, 322, 10.3389/fmicb.2012.00322 Yamano, 2012, Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis, Front Microbiol, 3, 389, 10.3389/fmicb.2012.00389 Hino, 1989, Milk-borne transmission of HTLV-I as a major route in the endemic cycle, Acta Paediatr Jpn, 31, 428, 10.1111/j.1442-200X.1989.tb01329.x Hino, 2011, Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki, Proc Jpn Acad Ser B Phys Biol Sci, 87, 152, 10.2183/pjab.87.152 Takezaki, 1997, Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group, Leukemia, S3, 60 Inaba, 1989, Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus: One-year experience, Transfusion, 29, 7, 10.1046/j.1537-2995.1989.29189101168.x Tajima, 1982, Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus, Gan, 73, 893 Stuver, 1993, Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study, J Infect Dis, 167, 57, 10.1093/infdis/167.1.57 Takezaki, 1995, Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic, J Infect Dis, 171, 559, 10.1093/infdis/171.3.559 Kaplan, 1996, Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group, J Acquir Immune Defic Syndr Hum Retrovirol, 12, 193, 10.1097/00042560-199606010-00014 Roucoux, 2005, A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II, J Infect Dis, 191, 1490, 10.1086/429410 Ishitsuka, 2015, Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma, Lancet Oncol, 15, e517, 10.1016/S1470-2045(14)70202-5 Glynn, 2002, International application of the incidence rate/window period model, Transfusion, 42, 966, 10.1046/j.1537-2995.2002.00200.x Schreiber, 1996, The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study, N Engl J Med, 334, 1685, 10.1056/NEJM199606273342601 Glynn, 2000, Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS), JAMA, 284, 229, 10.1001/jama.284.2.229 Carneiro-Proietti, 2012, Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007–2009, AIDS Res Hum Retroviruses, 28, 1265, 10.1089/aid.2011.0143 Zou, 2012, Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations, Transfus Med Rev, 26, 119, 10.1016/j.tmrv.2011.07.007 Prejean, 2011, Estimated HIV incidence in the United States, 2006–2009, PLoS One, 6, e17502, 10.1371/journal.pone.0017502 Mast, 2012, Population-based screening for anemia using first-time blood donors, Am J Hematol, 87, 496, 10.1002/ajh.23171 Karaosmanoglu, 2012, Seroprevalence of hepatitis B: do blood donors represent the general population?, J Infect Dev Ctries, 6, 181, 10.3855/jidc.2084 Atsma, 2011, Healthy donor effect: its magnitude in health research among blood donors, Transfusion, 51, 1820, 10.1111/j.1537-2995.2010.03055.x Sibon, 2015, Adult T-cell leukemia/lymphoma in a caucasian patient after sexual transmission of human T-cell lymphotropic virus type 1, Open Forum Infect Dis, 2, ofv032, 10.1093/ofid/ofv032 Osame, 1990, Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion, Ann Neurol, 28, 50, 10.1002/ana.410280110